Search

Displaying results 1281 - 1290 of 10000 in total
  1. Drug

    Ozanimod

    go.drugbank.com/drugs/DB12612
    ApprovedInvestigational

    in MS therapy. … It was developed by Celgene (now acquired by Bristol-Myers Squibb) [L11025] and was approved by the FDA on March 26, 2020.

    Products: ZEPOSİA 0,92 MG SERT KAPSÜL, 28 ADET
  2. Drug

    Cholestyramine

    go.drugbank.com/drugs/DB01432
    ApprovedInvestigational

    Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.

    Products: KOLESTRANTOZ 9 G POŞET, 60 ADET, ESTRAMIN TOZ, 12 ADET
  3. Drug

    Edotreotide gallium Ga-68

    go.drugbank.com/drugs/DB15494
    Approved

    [L8597] [Dotatate gallium Ga-68] is used for a similar indication.[A185852] Dotatate gallium Ga-68 has lower tumor uptake but this data is highly variable between patients. … [A185852] Edotreotide gallium Ga-68 was granted FDA approval on 21 August 2019.[L8597]

    Synonyms: Gallium Ga 68-dotatoc, Edotreotide Gallium Ga-68Products: Sogacin 20 MBq/ml Injektionslösung, Ga-68-DOTATOC
  4. Drug

    Baricitinib

    go.drugbank.com/drugs/DB11817
    ApprovedInvestigational

    [A248400] The EC later approved baricitinib for the treatment of atopic dermatitis, making it the first JAK inhibitor used for this indication in Europe. … [L41760] Baricitinib was first approved by the European Commission (EC) in February 2017 for the treatment of rheumatoid arthritis in adults [A248395] and was later approved by the FDA in 2018.

    Products: UNAMİTY 4 MG FİLM KAPLI TABLET, 7 ADET, UNAMİTY 4 MG FİLM KAPLI TABLET, 14 ADET
  5. Drug

    Etofenamate

    go.drugbank.com/drugs/DB08984
    Investigational

    It is a non-steroidal anti-inflammatory drug (NSAID).

    Mixtures: HOTFİX 100 MG/G + 10 MG/G KREM , 50 GRAM, THERMO RHEUMON 100 MG/G + 10 MG/G KREM, 50 GProducts: ETOVER 100 MG / ML SPREY, 50 ML, RHEUMON 100 MG/ML SPREY, 50 ML
  6. Drug

    Fesoterodine

    go.drugbank.com/drugs/DB06702
    Approved

    Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.

    Products: TOVIAZ 4 MG, TOVIAZ 4 mg prolonged-release tablets
  7. Drug

    Ioxitalamic acid

    go.drugbank.com/drugs/DB13444
    ApprovedWithdrawn

    [A27209] It is a first-generation contrast media formed by an ionic monomer with a high osmolarity of 1500-1800 mOsm/kg.

    Mixtures: TELEBRIX 35 FLAKON, 100 ML, TELEBRIX 35 FLAKON, 100 MLProducts: TELEBRIX 30 MEGLUMIN FLAKON, 100 ML, TELEBRIX 30 MEGLUMIN FLAKON, 30 ML
  8. Drug

    Methenamine

    go.drugbank.com/drugs/DB06799
    ApprovedInvestigationalVet approved

    In salt form it is used for the treatment of urinary tract infection (Example: methenamine hippurate which is the hippuric acid salt of methenamine).

    Mixtures: PURINOL 250 mg+615 mg/5 g EFERVESAN 140 GR, PURINOL 250 mg+615 mg/5 g EFERVESAN 140 GRProducts: NETURONE GRANUL LIBA, 70 G, URON 500 MG TABLET, 21 ADET
  9. Drug

    Doxazosin

    go.drugbank.com/drugs/DB00590
    ApprovedInvestigational

    [A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285]

    Products: DOKSURA 2 MG TABLET, 20 ADET, DOKSURA 4 MG TABLET, 20 ADET
  10. Drug

    Butamirate

    go.drugbank.com/drugs/DB13731
    Investigational

    Products: SINECOD 50 MG DEPO TABLET, 10 ADET, SINECOD 50 MG DEPO TABLET, 20 ADET